ArticleHeliyon2024
Leveraging electrocardiography signals for deep learning-driven cardiovascular disease classification model.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Wearable Devices and Machine Learning in Cardiovascular Monitoring: Current Evidence and Future Directions for Precision Medicine.Journal of personalized medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electrocardiography (ECG) is the most non-invasive diagnostic tool for cardiovascular diseases (CVDs). Automatic analysis of ECG signals assists in accurately and rapidly detecting life-threatening arrhythmias like atrioventricular blockage, atrial fibrillation, ventricular tachycardia, etc. The ECG recognition models need to utilize algorithms to detect various kinds of waveforms in the ECG and identify complicated relationships over time. However, the high variability of wave morphology among patients and noise are challenging issues. Physicians frequently utilize automated ECG abnormality recognition models to classify long-term ECG signals. Recently, deep learning (DL) models can be used to achieve enhanced ECG recognition accuracy in the healthcare decision making system. In this aspect, this study introduces an automated DL enabled ECG signal recognition (ADL-ECGSR) technique for CVD detection and classification. The ADL-ECGSR technique employs three most important subprocesses: pre-processed, feature extraction, parameter tuning, and classification. Besides, the ADL-ECGSR technique involves the design of a bidirectional long short-term memory (BiLSTM) based feature extractor, and the Adamax optimizer is utilized to optimize the trained method of the BiLSTM model. Finally, the dragonfly algorithm (DFA) with a stacked sparse autoencoder (SSAE) module is applied to recognize and classify EEG signals. An extensive range of simulations occur on benchmark PTB-XL datasets to validate the enhanced ECG recognition efficiency. The comparative analysis of the ADL-ECGSR methodology showed a remarkable performance of 91.24 % on the existing methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.